Amarin Share Discussion Threads

[lbo] 02/5/2007 11:09

Patrick no need to get emotional and resort to facetious comments. Everyone is entitled to an opinion. The market will decide if this is going to rise or fall. No amount of those comments will change the outcome but will change peoples perpective on you and lead them to question the validity of the reasons you put foward why this is worth holding. Although, I disgaree with you, I still respect your opinion and welcome reasoned debate which always leads to better investment decisions for all.

[keelingr] 01/5/2007 18:14

.....in response to an emal i sent them...


Thank you for your interest in Amarin. We were all disappointed in the trial results for Miraxion to treat Huntington's disease, and felt that it was necessary to get those top line results out to investors immediately rather than risk having the data leaked out in any other way. The complete analysis will take some time and the clinicians and researchers are diligently working to bring those results as expeditiously as possible.



Amarin has a pipeline of CNS products with tremendous potential. The company's novel, oral formulation of apomorphine for the treatment of "off" or "frozen" periods in advanced Parkinson's patients has a market potential of $100+ million. The company's recently licensed nasal formulation of lorazapam to treat seizures associated with epilepsy has a market potential of $300 million.



Currently, the company has approximately $29 million and feels confident that this can fund the company through to key data points for these very promising programs. The management team was recently strengthened with two key hires as they have the experience and industry know-how to move forward with these product candidates and to advise on potential in-licensing of other promising CNS drugs.



Management will be providing an update to investors on the progress, plans and timelines for Amarin's pipeline of products at two upcoming investor conferences. Rodman & Renshaw on May 15th and Banc of American on June 1st. Both of these investor presentations will be webcast and we urge you to listen in. More information about the specifics of the webcasts will be issued in advance of each conference.



Your continued support is greatly appreciated. We will continue to keep you apprised of the Company's progress.



Best regards,



Anne Marie

[patricktrfc] 01/5/2007 07:01

Do you two share a computer?? You're like those two old theatre critics on the Muppets!!

P

[lbo] 30/4/2007 23:10

Down another 4.73% in the US closing at 70c.

The trend seems to be one way!

[patricktrfc] 30/4/2007 13:44

LBO

You are right, there are better pharma investments around, just not many that are 80% down on a week ago. Most are priced at cash plus a massive markup for potential. We are priced at 2x cash only, even though we have potential niche markets, experienced mgmt etc etc.


Lemmings sold ICI down to 80p once and Atkins to 54p. Kept me in decent suits for a long while


Let's hope they can move the price the other way here too!


P

[lbo] 30/4/2007 13:36

Think there is better pharma investments around then this. This is now a punt and any rise will be on the back of lemmings. You may aswell ring Paddypower and have a few quid on Teofilo in the Guinneas!

[jonaston] 30/4/2007 12:54

THIS WILL FLY WHEN THE USA WAKE UP

[patricktrfc] 30/4/2007 08:52

LBO

It has enough cash for now and drugs in the pipeline, although not immediate

It also has the ex head of Pfizer R&D as an employee....he must have been enticed with positive possibilities


The main listing is in the US and that was rising on Friday...if it keeps rising today then don't fight the trend!


P

[lbo] 30/4/2007 08:29

patrick, I think the company is doing a good enough job on its own "to scare out" investors!

With its cash burn it barely has enough cash to last the year and from your own article all it has left is "a handful of highly-speculative, early-stage drug targets that could take many years to deliver a return"

[cheltspy] 29/4/2007 21:29

Indeed the main market is in the US, I have had two good day trades on this one, however the AIM listing is a hindrance, I wish they delist it!

[patricktrfc] 29/4/2007 21:04

Evening Tops

Why do you post on here as a non-holder of the stock?

Strikes me between you and LBO, you are making a concerted effort to scare out small holders, but it begs the question why...are you looking for a cheaper price or are you short?

Either way, the main market is in the US,not over here....our volume was 40,000 shares a day, in the US Nasdaq Friday it was 6 million..AND...it was up by 6½%



Another day like that on monday and the shorts will be thinking about covering quickly.

Best of luck either way

P

[topinfo] 29/4/2007 20:52

I wouldnt like to be holding this tomorrow, some serious losses to be made.

[topinfo] 29/4/2007 19:12

Tiiimmmbbbeeerrrr. Down she goes this week.!!!

[hermana] 29/4/2007 12:48

TOP,timber....................

[topinfo] 29/4/2007 12:28

Oooh dear, so glad I didnt buy on Friday. This could well wipe 50% off the share price over the next few trading days.!!!

[jonaston] 29/4/2007 11:12

This share is on the turn so if you want any now is ya chance

[topinfo] 28/4/2007 21:42

Think it still has another 20-25% to fall. I will be a buyer or should I say gambler at 30-32p.

[lbo] 28/4/2007 12:10

All confidence by investors and the brokers is now gone in the guys who were involved in Elan and now Amarin IMHO.

"There were also some bitter pills to be swallowed by followers of the pharma sector.

Elan lost 5pc to €10.28 as a disappointing uptake of the group's multiple sclerosis treatment Tysabri, which was relaunched last year, led to the company posting a wider-than-expected first quarter loss of $93m.

But Elan's woes pale in comparison to Amarin's 80pc share price collapse after it said that its pipeline Huntington's disease drug Miraxion had failed in two late stage trials.

The news was all the more shocking following a decent run by the stock, particularly in light of broker upgrades from Davy Stockbrokers and Goodbody Stockbrokers in recent weeks amid high hopes for the drug"

[topinfo] 27/4/2007 18:13

So quiet on here for a stock thats fallen from over £2.00 to 39 in the same week. Looks like its not a stock commonly held by PIs, probably more institutions, which is why the dramatic fall has taken place. Sure these will go up again but just cant bring myself to buy yet as think they may go lower, possibly 30p before the upturn.

[topinfo] 27/4/2007 16:04

The spread puts me off 38 v 41.5 and no discount to the offer price.

[patricktrfc] 27/4/2007 15:35

Now up 10.76% in the US